Seller record · Telehealth service

SkinnyRx

Fails 2 of 8 criteria. S3, pharmacy identification: The terms, privacy, questions and treatment pages each refer to a partner pharmacy or to 503A pharmacies as a category, and no facility is named. 1 more criterion also fails; see the table below.

At a glance

SkinnyRxTelehealth service

6/8criteria passed
Price
First month from $99 (no later price printed)
Sells
compounded semaglutide injections and tablets, and 3 more
FDA letters
1 on file

Partner link. The site earns a commission on care started through it. Funding

Visit SkinnyRxSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide as injections and tablets, alongside brand GLP-1 prescriptions. Its pages render only in a browser, and its address appears in the terms and the privacy policy rather than on its contact page.

Operating entity Lean Rx, Inc.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSSkinnyRx's contact page
S2Prescription gatingPASSSkinnyRx's intake page
S3Pharmacy identificationFAILSkinnyRx's FAQ
S4Compounding disclosurePASSSkinnyRx's website
S5Analytical documentationFAILSkinnyRx's semaglutide injectable product page
S6Business addressPASSSkinnyRx's terms
S7Price disclosurePASSSkinnyRx's website
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe questions page states that a licensed clinician reviews the medical intake and that a video visit may follow, and it names no individual prescriber.Source: SkinnyRx's contact page.
S2PASSA fifteen-step medical intake opening on a weight-loss goal comes before any payment field.Source: SkinnyRx's intake page.
S3FAILThe terms, privacy, questions and treatment pages each refer to a partner pharmacy or to 503A pharmacies as a category, and no facility is named.Source: SkinnyRx's FAQ.
S4PASSA notice on the homepage states that compounded drugs are not Food and Drug Administration approved or evaluated for safety, effectiveness or quality.Source: SkinnyRx's website.
S5FAILThe treatment pages state that partner pharmacies run third-party quality-control checks on every compounded lot, and no certificate or lot report is reachable from any page on the site.Source: SkinnyRx's semaglutide injectable product page.
S6PASSThe terms and the privacy policy both print a street address with a suite on N Street in Sacramento, California, while the contact page gives only an email address and a telephone number.Source: SkinnyRx's terms.
S7PASSThe homepage prints three first-month figures with no account required: 99 dollars, 149 dollars and 199 dollars, each described as the first month.Source: SkinnyRx's website.
S8PASSFDA warning letter 717989, February 2026, names Lean Rx, Inc. doing business as SkinnyRx at the Sacramento address this site prints, and cites claims of the same active ingredient as an approved drug. No FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injections and tablets, compounded tirzepatide injections and tablets, Wegovy, Foundayo.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatide

Enforcement documents on file: 1 warning letter

FDA warning letter 717989, issued February 2026, to Lean Rx, Inc. dba SkinnyRxClaims on SkinnyRx's website that compounded products give the same active ingredient as name-brand GLP-1 medications are false or misleading.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Partner link. The site earns a commission on care started through it. Funding.

Visit SkinnyRx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.